A Comparison of AmBisome(®) to Amphotericin B for Treatment of Systemic Candidiasis in Very Low Birth Weight Infants

PURPOSE: Amphotericin B is considered the treatment of choice for systemic candidiasis, but adverse effects may limit its use. An alternative option for the treatment of candidiasis includes lipid preparations of amphotericin B. This study investigated the safety and efficacy of AmBisome(®), a lipid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jeon, Ga Won, Koo, Soo Hyun, Lee, Jang Hoon, Hwang, Jong Hee, Kim, Sung Shin, Lee, Eun Kyung, Chang, Wook, Chang, Yun Sil, Park, Won Soon
Formato: Artigo
Idioma:Inglês
Publicado em: Yonsei University College of Medicine 2007
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2628045/
https://ncbi.nlm.nih.gov/pubmed/17722233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2007.48.4.619
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados